Understand the source comparison
The Neuroinflammatory vs Vascular Distinction
Long COVID brain fog isn't a monolithic condition. It's the downstream result of at least two distinct upstream failures. Neuroinflammatory brain fog results from sustained microglial activation triggered by viral antigens or autoantibodies crossing the blood-
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Long COVID brain fog isn't a monolithic condition. It's the downstream result of at least two distinct upstream failures. Neuroinflammatory brain fog results from sustained microglial activation triggered by viral antigens or autoantibodies crossing the blood-brain barrier during acute infection. Once activated, microglia release IL-1β, TNF-α, and other pro-inflammatory cytokines that suppress BDNF (brain-derived neurotrophic factor) expression in the hippocampus and prefrontal cortex. BDNF is required for neurogenesis and synaptic plasticity. When it drops below baseline by 30% or more, cognitive processing slows measurably. A 2024 study from Yale found persistently elevated microglial markers in CSF samples from long COVID patients with brain fog 18 months post-infection. The inflammation doesn't resolve spontaneously in most cases.
- Vascular brain fog, by contrast, stems from endothelial dysfunction. SARS-CoV-2 binds ACE2 receptors on endothelial cells lining cerebral blood vessels, triggering microthrombosis and reduced nitric oxide bioavailability. The result: cerebral hypoperfusion. MRI perfusion studies from Stanford documented 15–22% reductions in blood flow to frontal and temporal lobes in long COVID patients with cognitive complaints compared to age-matched controls. Reduced perfusion starves neurons of glucose and oxygen. Even if the neurons themselves are structurally intact. This is mechanistically different from inflammation suppressing neurogenesis.
- Semax works on the neuroinflammatory pathway by upregulating BDNF gene expression through activation of the TrkB receptor and downstream PI3K/Akt signaling. It doesn't improve blood flow. BPC-157 promotes angiogenesis and endothelial repair through VEGF receptor activation. It improves perfusion but doesn't directly modulate neuroinflammation. Selank reduces the cortisol-driven perpetuation of inflammation by stabilizing GABAergic tone but doesn't address vascular dysfunction. The peptides aren't interchangeable. Our team has seen patients trial Selank for vascular-driven brain fog and report zero improvement. Not because the peptide doesn't work, but because it wasn't addressing the active mechanism.